Etoricoxib-Cannabidiol Combo: Potential Role in Glioblastoma Treatment and Development of PLGA-Based Nanoparticles
Pharmaceutics · 09.08.2023 · 15 (8) · 2104
DOI: 10.3390/pharmaceutics15082104 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 09.08.2023. Verfasst von Joanna Kuźmińska und 8 weiteren Autor:innen. Beteiligte Einrichtung: Chair and Department of Pharmaceutical Chemistry, Poznan University of Medical Sciences, Grunwaldzka 6, 60-780 Poznań, Poland. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Poznan University of Medical Sciences.
Abstract (Originalsprache)
Background
Glioblastoma (GBM) is the most frequently occurring primary malignant central nervous system tumor, with a poor prognosis and median survival below two years. Administration of a combination of non-steroidal anti-inflammatory drugs and natural compounds that exhibit a curative or prophylactic effect in cancer is a new approach to GBM treatment. This study aimed to investigate the synergistic antitumor activity of etoricoxib (ETO) and cannabidiol (CBD) in a GBM cell line model, and to develop poly(lactic-co-glycolic acid) (PLGA)-based nanoparticles (NPs) for these two substances.
Methods
The activity of ETO+CBD was determined using the MTT test, cell-cycle distribution assay, and apoptosis analysis using two GBM cell lines, namely, T98G and U-138 MG. The PLGA-based NPs were developed using the emulsification and solvent evaporation method. Their physicochemical properties, such as shape, size, entrapment efficiency (EE%), in vitro drug release, and quality attributes, were determined using scanning electron microscopy, diffraction light scattering, high-performance liquid chromatography, infrared spectroscopy, and differential scanning calorimetry.
Results
The combination of ETO and CBD reduced the viability of cells in a dose-dependent manner and induced apoptosis in both tested GBM cell lines. The developed method allowed for the preparation of ETO+CBD-NPs with a spherical shape, mean particle size (MPS) below 400 nm, zeta potential (ZP) values from −11 to −17.4 mV, polydispersity index (PDI) values in the range from 0.029 to 0.256, and sufficient EE% of both drugs (78.43% for CBD, 10.94% for ETO).
Conclusions
The combination of ETO and CBD is a promising adjuvant therapeutic in the treatment of GBM, and the prepared ETO+CBD-NPs exhibit a high potential for further pharmaceutical formulation development.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Chair and Department of Pharmaceutical Chemistry, Poznan University of Medical Sciences, Grunwaldzka 6, 60-780 Poznań, Poland.
- Doctoral School, Poznan University of Medical Sciences, Bukowska 70, 60-812 Poznań, Poland.
- Chair and Department of Pharmaceutical Biochemistry, Poznan University of Medical Sciences, Święcickiego 4, 60-781 Poznań, Poland.
- Chair and Department of Pharmaceutical Technology, Poznan University of Medical Sciences, Grunwaldzka 6, 60-780 Poznań, Poland.
ORCID-Profile: Agnieszka Sobczak, Aleksandra Majchrzak-Celińska, Aleksandra Gostyńska, Barbara Jadach, Violetta Krajka-Kuźniak, Maciej Stawny
Förderung
- Poznan University of Medical Sciences
Zitieren
APA
Kuźmińska, J., Sobczak, A., Majchrzak-Celińska, A., Żółnowska, I., Gostyńska, A., Jadach, B., Krajka-Kuźniak, V., Jelińska, A., & Stawny, M. (2023). Etoricoxib-Cannabidiol Combo: Potential Role in Glioblastoma Treatment and Development of PLGA-Based Nanoparticles. Pharmaceutics, 15(8), 2104. https://doi.org/10.3390/pharmaceutics15082104
Vancouver
Kuźmińska J, Sobczak A, Majchrzak-Celińska A, Żółnowska I, Gostyńska A, Jadach B, et al. Etoricoxib-Cannabidiol Combo: Potential Role in Glioblastoma Treatment and Development of PLGA-Based Nanoparticles. Pharmaceutics. 2023;15(8):2104. doi:10.3390/pharmaceutics15082104
BibTeX
@article{Kumiska2023,
author = {Kuźmińska, Joanna and Sobczak, Agnieszka and Majchrzak-Celińska, Aleksandra and Żółnowska, Izabela and Gostyńska, Aleksandra and Jadach, Barbara and Krajka-Kuźniak, Violetta and Jelińska, Anna and Stawny, Maciej},
title = {Etoricoxib-Cannabidiol Combo: Potential Role in Glioblastoma Treatment and Development of PLGA-Based Nanoparticles},
journal = {Pharmaceutics},
year = {2023},
volume = {15},
number = {8},
pages = {2104},
doi = {10.3390/pharmaceutics15082104}
}
EUVIMED